Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.

@article{Dmochowski2002EfficacyAS,
  title={Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.},
  author={Roger R Dmochowski and Guillermo Willy Davila and Norman R. Zinner and Marc C Gittelman and Daniel R Saltzstein and Sydney Lyttle and Steven W. Sanders},
  journal={The Journal of urology},
  year={2002},
  volume={168 2},
  pages={580-6}
}
PURPOSE We evaluated the efficacy and safety of an oxybutynin transdermal delivery system (TDS) in a general population of patients with overactive bladder and urge or mixed urinary incontinence. MATERIALS AND METHODS Following symptom stabilization or treatment withdrawal 520 adult patients were randomized to 12 weeks of double-blind daily treatment with 1.3, 2.6 or 3.9 mg. oxybutynin TDS or placebo administered twice weekly, followed by a 12-week open-label, dose titration period to assess… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

Transdermal Oxybutynin

View 9 Excerpts
Highly Influenced

Oxybutynin: an overview of the available formulations

Therapeutics and clinical risk management • 2006
View 1 Excerpt
Highly Influenced

Similar Papers

Loading similar papers…